The Romanian Association for Services and Communication in Oncology Receives Recognition for Commitment to Advocacy for Lung Cancer

Friday, August 16, 2019

ProposalMasthead_0318-01.pngContact:

Becky Bunn
Becky.Bunn@IASLC.org | 720-325-2946

Chris Martin
Cmartin@davidjamesgroup.com | 630.670.2745  

The Romanian Association for Services and Communication in Oncology Receives Recognition for Commitment to Advocacy for Lung Cancer

DENVER – The Romanian Association for Services and Communication in Oncology (ASPCO) will receive the Advocate Travel Award from the International Association for the Study of Lung Cancer (IASLC) at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain, in September.

ASPCO is a volunteer-based organization that supports Romanian lung cancer patients. Through involvement with the IASLC, ASPCO is hoping to help share the “Hope Lives” advocacy message about Romanian lung cancer patients and survivors during Lung Cancer Awareness Month in November.

“Lung cancer burden and mortality rate are significant problems in Romania,” said Csaba Laszlo Degi, a patient advocate for ASPCO. “We want to increase lung cancer patients’ voices through transformative research. Our final goal with research is to have compassionate and supportive treatment for all cancer patients, making lung cancer survivorship visible in all of Romania.”

As an Advocate Travel Award winner, ASPCO will receive complimentary conference registration, a fixed monetary amount to help offset travel costs, four nights’ accommodation at one of the Conference contracted hotels and free IASLC membership for 2020, allowing ASPCO to continue their advocacy for lung cancer.

About the WCLC:

The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. 

###


About the Author

Chris Martin, Vice President, Public Relations